Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

Back

HFA Premium Access

Use of trimetazidine in myocardial damage by Covid 19 and LVEF recovery.

Session: ePosters in chronic heart failure - pharmacotherapy 2

Topic: Pharmacotherapy

Speaker: Doctor R. Rascon Sabido (Veracruz, MX)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Rafael Rascon Sabido

Mexican Institute of Social Security (IMSS), Veracruz (Mexico)

1 presentation

0 follower

6 more presentations in this session

Aspirin and long-Term risk of heart failure in patients with high atherosclerotic risk

Speaker: Associate Professor W. Wongcharoen (Chiang Mai, TH)

Access

Abstract

Slides

Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure

Speaker: Doctor M. Davies (The Woodlands, US)

Access

Abstract

Slides

Utility of a heart failure treatment score (quad score) in predicting early outcomes in patients with heart failure and a reduced ejection fraction

Speaker: Doctor B. Li (Basildon, GB)

Access

Abstract

Slides

Reverse cardiac remodeling effects of sacubitril/valsartan in adults with congenital heart disease

Speaker: Doctor A. Ferreira (Lisbon, PT)

Access

Abstract

Slides

Prevalence of sodium glucose co-transporter 2 inhibitor related erythrocytosis (polycythaemia) in real world heart failure patients: a warning for the daily clinical practice

Speaker: Mr E. Bruwiere (Nijmegen, NL)

Access

Abstract

Slides

Access the full session

ePosters in chronic heart failure - pharmacotherapy 2

Speakers: Doctor R. Rascon Sabido, Associate Professor W. Wongcharoen, Doctor M. Davies, Doctor B. Li, Doctor A. Ferreira...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources